EEMEA Talks - Hemostasis

Welcome to New Frontiers, the podcast where Hemostasis meets innovation. In this fourth episode, we spotlight Heparin-Induced Thrombocytopenia (HIT), a critical condition that demands swift diagnosis to prevent life-threatening complications. Together with Rossella Marcucci, Full Professor of Internal Medicine at the University of Florence and Director of the “Atherothrombotic Diseases” unit at Careggi University Hospital, we’ll discover the differences between Type I and Type II HIT, explore its pathophysiology, and highlight how automated testing can accelerate diagnosis, reduce uncertainty, and help clinicians avoid unnecessary treatment shifts. Join us in pushing boundaries and powering better patient care!

Welcome to New Frontiers, the podcast where Hemostasis meets innovation. In this third episode, I’m joined once again by Dr. Marco Foracchia, Chief Information Officer at Azienda Unità Sanitaria Locale – IRCCS Reggio Emilia. Together, we’ll explore the critical topic of cybersecurity in healthcare, examining key regulatory frameworks, the role of risk assessments and contingency planning, and practical strategies for implementation. Tune in for an engaging conversation on how technology and preparedness are shaping the future of cybersecurity in this complex and evolving sector.

Welcome to New Frontiers, the podcast where Hemostasis meets innovation. In this second episode, I’m joined by Dr. Marco Foracchia, Chief Information Officer at Azienda Unità Sanitaria Locale – IRCCS Reggio Emilia, for an insightful conversation on cybersecurity in healthcare. Together we’ll uncover why hospitals are prime targets for cyberattacks, the specific vulnerabilities they face, and how data protection compares across critical sectors. We’ll also break down common attack methods and practical strategies to prevent and respond to threats. Tune in to discover key insights and best practices for navigating today’s cybersecurity challenges in one of the most complex sectors.

Welcome to New Frontiers, the podcast where Hemostasis meets cutting-edge innovation. In our debut episode, we dive into the world of data with Dr. Panagiotis Tsiamyrtzis, a leading voice in Statistical Process Control and Bayesian methods, teaching at Politecnico di Milano and the Athens University of Economics and Business. Together, we’ll explore the strengths and limitations of Frequentist versus Bayesian approaches, and discover how Bayesian models—adaptive, self-starting, and powered by prior knowledge—can revolutionize Quality Control, especially when data is scarce. Tune in and find out how smart statistics are reshaping the future of Hemostasis. 

I’m Nusaiba, at 20 I had a two pulmonary embolism 10 months apart while studying at university. It was devastating and impacted every aspect of my life, I was completely unaware of how difficult recovery can be and did not know anything about some of the unexpected side effects of blood thinners. Four years down the line, I have had to adjust to a new normal where life involves a lot of hospital appointments! As a young person with a clot I had to navigate recovery while finishing my degree and now working full time, while also trying to enjoy life as a young person! I hope by sharing my story both patients and clinicians will learn about the complexities of having blood clots and that recovery can be very hard but you will get better!  

I’m Priyanka Sardana-Gakhar—friends call me Priya—a 29-year-old soccer player from Sydney, Australia. At 22, I earned a scholarship to play NCAA D1 in the U.S. and moved to Louisiana. My life took a sharp turn after a 14-hour flight back to cold Canberra, where I was diagnosed with multiple blood clots in my lungs. As an athlete, it’s easy to dismiss symptoms, and often, others do too. I’m sharing my story to make sure no one else goes through this, and to remind everyone to keep pushing for answers, no matter what.

Lainey is a research technician for an Alzheimer's and Aging Laboratory. She graduated from Iowa State University with her bachelor’s degree in Animal Science. While at Iowa State, Lainey experienced two clotting events. Lainey is a proud, two time pulmonary embolism survivor. A latin proverb states,“by teaching, we learn”.  Lainey uses this phrase to influence her personal life and her life spreading awareness around the risks, signs and symptoms of blood clots. When she isn’t in the laboratory, you can find Lainey with a camera in hand photographing pets and wildlife, or at home baking and crafting with her two labradors and three orange kitties by her side.   

I’m Ellie Bradford, 24, from the UK. I had my first blood clot at just 16 years old due to May-Thurner Syndrome and the combined pill, and another unprovoked DVT at 24. Now on lifelong blood thinners, I want to raise awareness that blood clots can happen to anyone. Sharing my story is my way of helping others recognize the signs and push for the right diagnosis.   

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the final episode of our podcast series on Women and Bleeding Disorders, we close our discussion with Dr. Lucia Rugeri, a specialist in clinical hemostasis, discussing the challenges of the management of bleeding disorders with special attention to challenges faced in the management of women-specific conditions. We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the third episode of our podcast series on Women and Bleeding Disorders, we continue exploring with Dr. Lucia Rugeri, a specialist in clinical hemostasis, what is the situation of Patient Access to care, the state of the Education of patients and healthcare professionals on the topic, and how to Diagnose Bleeding Disorders with a special focus on women.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.